Travelling to Another City for a Clinical Trial — What It Actually Involves

Screening first, then a fixed schedule of visits set by the protocol. Early cycles are usually the most frequent, often weekly or fortnightly, with extra bloods, scans and questionnaires added to the treatment itself. Expect several times more hospital days than routine care, for months rather than weeks.

Most families weigh the distance. The distance is rarely the problem. What decides whether a trial in Hyderabad, Bengaluru, Mumbai or Delhi is workable for a family from a district town is how many times you have to make that journey, how narrow the window around each date is, and where you sleep on the nights in between. A protocol is written for clean data, not for your bus timetable, and it does not bend.

This page is informational, not a recruitment page. It explains what travelling for a study in India involves. CION does not run, host or recruit for clinical trials, cannot offer you a place in one, and nothing here is an invitation to join a study. Eligibility is decided by screening at the trial site, and most people who enquire about a specific study do not meet its criteria.

More often than routine treatment, almost always. Standard immunotherapy is commonly given every two, three or six weeks in day care. A trial adds safety bloods, observation periods, questionnaires and protocol scans, so early cycles can mean weekly attendance. Ask the site for the full visit calendar in writing.

• Screening is a journey on its own. Consent, bloods, imaging and sometimes a repeat biopsy, spread over one to four weeks — and it can still end with you being found ineligible.
• Cycle one is the heaviest. First doses are watched closely. Expect longer days, extra bloods at fixed hours, and in some studies an overnight stay after the first administration.
• The rhythm settles, but never to zero. Later cycles are more predictable, though still more frequent than the same treatment given as standard care outside a study.
• Scans run on the protocol's clock. Response assessment happens on fixed weeks whether or not you feel any different. At CION, response-assessment PET-CT is coordinated at partner imaging centres rather than owned in-house, and every trial site has its own imaging arrangements — ask where each scan is done.
• Side effects add visits nobody planned. An unscheduled review can mean travelling at two days' notice, which is why families who move for a trial keep some leave and some money held back.
• Follow-up outlives the treatment. Data collection continues for months or years after the last dose, usually as a mix of visits and telephone contact.

Ask one question before anything else: how many in-person visits, over how many months? Any site running a genuine study can answer that in writing on the day you ask. A vague answer is information in itself.

Travel and incidental costs are often reimbursed, within a ceiling the ethics committee has approved under the ICMR National Ethical Guidelines. Accommodation usually is not. Reimbursement is designed around visit-day travel, not around a family living elsewhere for months, which is the gap that most often ends participation early.

• It is reimbursement, not payment. The purpose is that taking part should not leave you poorer. It is not a fee, and it is not compensation for risk.
• The ethics committee fixes the amount. Deliberately modest, so that money cannot become the reason a person agrees to take part. The site cannot quietly raise it, and should not quietly reduce it.
• Lost wages can sometimes be included. Where the committee has approved it, a day's lost earnings for the participant, and occasionally for one attendant, may be reimbursed. Ask specifically.
• Accommodation is the usual shortfall. Months of rent near a hospital in another city is the cost families underestimate most, and it is rarely covered by anything.
• Your routine care is still billed. The study drug and protocol-only tests are normally the sponsor's cost; registration, admission and ordinary investigations usually are not. Is Treatment Free in a Clinical Trial? sets out the full split.
• Ask three questions, get them in writing. How much is approved, what receipts are needed, and how long payment takes.

If you have Aarogyasri, CGHS, ECHS, ESI or a private policy, ask the trial site how the routine part of your care will be billed while you are on study, and whether being treated outside your home state changes the claim. Joining a study does not automatically change how those claims are processed, and the answer differs between hospitals.

Eight steps, in this order: confirm the trial on CTRI, have your oncologist refer you, get the visit calendar in writing, ask what the longest day looks like, settle accommodation, get reimbursement terms in writing, arrange the care that stays at home, and ask what happens if you stop.

1. 1

   Confirm the trial exists on CTRI before you travel

   Every trial legally running in India must be registered with the Clinical Trials Registry - India, maintained by ICMR. The entry names the sponsor, the participating sites and a contact. If the study you have been told about is not there, that is your answer, and no journey is needed.

2. 2

   Ask your treating oncologist to make the referral

   Sites screen patients; patients do not enrol themselves. Your oncologist can send your reports ahead and ask two questions: is recruitment still open, and do you fit the criteria on paper. Both answers can be had without anyone leaving the state.

3. 3

   Ask for the full visit calendar in writing

   Not the number of cycles. The number of visits, over how many months, and how wide the window is around each date. This single document decides whether the move is workable for your family, and any site running a real study can produce it.

4. 4

   Ask what happens on the longest day

   Some visits are twenty minutes and some are eight hours with observation afterwards. Ask which visits need an overnight stay, which need someone with you, and which are the ones you must not miss. Then plan around those, not around the average.

5. 5

   Settle where you will live before you accept a place

   Screening and the first cycle are usually the heaviest weeks. Many families stay near the site for that period and travel in afterwards. Ask the site whether it knows of patient accommodation, dharamshalas or a social worker who handles this - most large centres do.

6. 6

   Get the reimbursement terms in writing

   Ask what the ethics committee has approved for travel, wages lost and incidental costs, what receipts you must keep, who you submit them to and how long payment takes. Check it against the Participant Information Sheet, because that document is what counts.

7. 7

   Arrange the care that stays at home

   Your other medicines, your local oncologist, your scheme or insurance paperwork and any dependent who needs looking after do not pause because you have travelled. Name one person locally who holds your reports, and carry copies of everything with you.

8. 8

   Ask what happens if you have to stop, or go home

   You can withdraw at any point, without giving a reason and without losing your usual care. Before signing, ask what your treatment would revert to, whether it can be given near home, and who would hand you back to your local team.

Most of these steps can be completed by phone and email from where you live. Travelling should be the last step, not the first — and How to Find an Immunotherapy Clinical Trial in India covers the search itself, before any of this begins.

Six things, and all of them by phone or email first. Whether recruitment is open, whether you fit the criteria on paper, the full visit calendar, which visits must be in person, what reimbursement has been approved, and who pays if the study harms you. None of that requires a journey.

• Is recruitment still open, and do I fit on paper? Sites close enrolment once the required number is reached. Your oncologist can send reports ahead and get both answers before anyone travels.
• How many in-person visits, over how many months? Ask for the calendar as a document. Then ask how wide the window is around each date.
• Which visits can be done locally or by telephone? Usually few, because protocol procedures must be done by trained site staff. Ordinary supportive care can sometimes be shared with your local oncologist, if the site agrees in advance.
• What does the longest day look like? Observation periods, timed bloods and overnight stays change what accommodation you need and whether someone must come with you.
• What has the ethics committee approved for reimbursement? Amount, receipts, who to submit to, how long payment takes — checked against the Participant Information Sheet.
• Who pays if I am harmed, and who do I call at night? Under the New Drugs and Clinical Trials Rules, 2019, medical management of a trial-related injury must be provided free for as long as it is needed. Get a number that works at 2am before you are five hundred kilometres from home.

When the visit calendar cannot realistically be met, when nobody can accompany you, when the standard treatment available near home is a reasonable option, or when the honest answer is that treatment itself is no longer the priority. A trial is one option among several, not the only serious one.

• Investigational means unproven. The study exists because the answer is not yet known. Anyone describing a trial drug as a certainty for you is describing something the trial has not established. Will I Get a Placebo in a Cancer Trial? explains what the comparison arm in a cancer study usually contains.
• Nobody can promise you a place. Screening decides. Treat any assurance of entry — from a hospital, an agent or a website — as a reason to step back.
• A calendar you cannot meet helps nobody. Missed visits are recorded as deviations and can end participation. Being honest with the site about what you can attend is better than agreeing and then failing.
• Standard treatment near home is a real option. For many diagnoses there is an approved treatment available in Telangana and Andhra Pradesh that does not require moving. Ask what it is and what it involves before you weigh a study against it.
• Not treating is also a legitimate choice. In some situations best supportive care, given close to family, is a considered decision rather than a failure, and it should be discussed openly rather than raised last.
• You can leave at any point. Withdrawing does not cost you your usual care. Ask before signing what your treatment would revert to and who would hand you back to your local team.

Four things, in the order families usually ask them: how to find a study at all, whether the treatment is actually free, whether you might be given a placebo, and how immunotherapy is delivered as a pathway. Read the first two before you plan any journey.

• How to Find an Immunotherapy Clinical Trial in India — where to search, what CTRI shows you, and why the referral has to come from your treating oncologist.
• Is Treatment Free in a Clinical Trial? — what the sponsor pays for, what stays on your bill, and how reimbursement is decided.
• Will I Get a Placebo in a Cancer Trial? — what randomisation would mean for you, and what comparison arms in cancer studies really contain.
• Immunotherapy at CION Cancer Clinics — how eligibility review, day-care treatment and monitoring fit together as one pathway close to home.

No Rushed Decisions. No Promises We Cannot Keep.

Every plan is reviewed by a tumour board, and every family is told what is certain and what is not before treatment starts.